OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Help
Advanced
Search
141
Results
Show all
Save search
Copy query
Show results for
Unknown
(103)
Metabolomics
(32)
Clinical
(3)
Transcriptomics
(1)
Proteomics
(1)
Genomics
(1)
Organisms
Homo sapiens
(1)
Alphavirus
(1)
Anemia
(1)
Betaherpesvirinae
(1)
Brassica oleracea var. oleracea
(1)
Cowpox virus
(1)
Coxsackievirus
(1)
Cytomegalovirus
(1)
Dengue virus
(1)
EFO:0001352
(1)
Filoviridae
(1)
Hepatitis B virus
(1)
Human alphaherpesvirus 1
(1)
Human betaherpesvirus 5
(1)
Human immunodeficiency virus
(1)
Human immunodeficiency virus 1
(1)
Human immunodeficiency virus 2
(1)
Influenza A virus
(1)
Influenza C virus
(1)
Japanese encephalitis virus group
(1)
Lyssavirus rabies
(1)
Monkeypox virus
(1)
Nostoc sp. PCC 7120 = FACHB-418
(1)
Oropouche virus
(1)
Orthopoxvirus
(1)
Orthopoxvirus vaccinia
(1)
Rattus
(1)
Staphylococcus aureus
(1)
Streptococcus pneumoniae
(1)
Viruses
(1)
Repository
MetaboLights
(26)
MetabolomicsWorkbench
(6)
biostudies-arrayexpress
(1)
pride
(1)
ENA
(1)
Tissue
Blood
(4)
Feces
(1)
Urine
(1)
Cell culture
(1)
Disease
COPD
(3)
Bowel Obstruction
(1)
Thyroid Cancer, Papillary
(1)
Prostate Cancer
(1)
Irritable bowel syndrome
(1)
Technology Type
Mass spectrometry
(14)
Mass spectrometry assay
(12)
Mass Spectrometry
(7)
ESI
(6)
Shotgun proteomics
(1)
Instrument Platform
Liquid Chromatography MS - positive - reverse phase
(9)
Liquid Chromatography MS - negative - reverse phase
(9)
Q Exactive
(4)
Liquid Chromatography MS - positive - hilic
(4)
Liquid Chromatography MS - negative - hilic
(3)
Liquid Chromatography MS - alternating - reverse-phase
(2)
Liquid Chromatography MS - negative - HILIC
(2)
Liquid Chromatography MS - positive - HILIC
(2)
Liquid Chromatography MS - negative - reverse-phase-c18
(1)
Liquid Chromatography MS - positive - hydrophilic-interaction-liquid-chromatography
(1)
Liquid Chromatography MS - positive - reverse-phase-c18
(1)
Liquid Chromatography MS - negative - hydrophilic-interaction-liquid-chromatography
(1)
Flow injection analysis MS -
(1)
Direct infusion MS - negative
(1)
Liquid Chromatography MS - Negative (LC-MS (Negative))
(1)
Liquid Chromatography MS - Positive (LC-MS (Positive))
(1)
Direct infusion MS - positive
(1)
Liquid Chromatography MS - negative - reversed-phase-chromatography
(1)
Liquid Chromatography MS - positive - reverse-phase
(1)
Liquid Chromatography MS - negative - reverse-phase
(1)
Publication Date
2026
(10)
2021
(5)
2022
(4)
2025
(3)
2024
(2)
2023
(2)
2012
(1)
2020
(1)
CHEBI ID
CHEBI:4975
(12)
CHEBI:17562
(10)
CHEBI:17012
(10)
CHEBI:18211
(10)
CHEBI:16704
(10)
CHEBI:89182
(9)
CHEBI:68567
(9)
CHEBI:18257
(9)
CHEBI:17533
(9)
CHEBI:6650
(9)
CHEBI:71466
(9)
CHEBI:15727
(9)
CHEBI:27468
(9)
CHEBI:16335
(9)
CHEBI:7916
(9)
CHEBI:15891
(9)
CHEBI:24813
(9)
CHEBI:43355
(9)
CHEBI:30915
(9)
CHEBI:26078
(9)
CHEBI:70976
(9)
CHEBI:17687
(9)
CHEBI:30769
(9)
CHEBI:25351
(8)
CHEBI:27410
(8)
CHEBI:16390
(8)
CHEBI:26984
(8)
CHEBI:25722
(8)
CHEBI:48430
(8)
CHEBI:60175
(8)
Metabolite Name
Famotidine
(21)
Uridine
(12)
Taurine
(11)
Hypoxanthine
(11)
4-Pyridoxic acid
(10)
N1-Methyl-2-pyridone-5-carboxamide
(9)
Genistein
(9)
Biliverdin
(9)
Urocanic acid
(9)
Oleic acid
(9)
N-acetyltryptophan
(9)
Linoleic acid
(9)
L-Glutamine
(9)
Hexadecanedioic acid
(9)
Dodecanedioic acid
(9)
Azelaic acid
(9)
Cytidine
(9)
Guanosine
(9)
Creatine
(9)
Glycerophosphocholine
(9)
L-Valine
(9)
N-acetylhistidine
(8)
Phenol
(8)
Indoxyl sulfate
(8)
Ornithine
(8)
L-Histidine
(8)
Xanthosine
(8)
Arachidonic acid
(8)
Guanine
(8)
Riboflavin
(8)
First Public Date
2026
(1)
Study status
Completed
(2)
Recruiting
(1)
Study type
Interventional
(3)
Transcription profiling by array
(1)
Release Date
2021
(19)
2022
(17)
2020
(17)
2023
(13)
2025
(7)
2024
(6)
2026
(4)
2013
(4)
2019
(3)
2016
(3)
2015
(3)
2012
(2)
2018
(2)
2017
(1)
2014
(1)
2011
(1)
2005
(1)
Lab affiliation
Institue of Biochemistry 2, Buchmann institute for Molecular Life Sciences
(1)
Location
Iran
(1)
United States
(1)
Australia
(1)
Keyword
Famotidine
(1)
Previous
page
1 / 15
You're on page
1
page
2
page
3
page
4
page
5
page
...
page
15
Next
page
Sort
by:
Relevance
Page size
10
Famotidine targets Toll-like receptor 3 signaling in SARS-CoV2 infection
Caco2 cells were pretreated with 100µM histamine and 50µM Famotidine for 12h followed by infection with SARS-CoV2 for 24h. After that proteome was analysed.
ORGANISM(S):
Homo sapiens (Human)
2022-02-17
|
PXD025703
|
Pride
Famotidine
Sars-cov2
Toll-like receptor
Histamine
Anti-viral signaling
Cite
Famotidine increases cellular phospho-tyrosine levels.
Not available
S-EPMC11490372
|
biostudies-literature
Cite
Famotidine Enhances Rifampicin Activity against Acinetobacter baumannii by Affecting OmpA.
Not available
S-EPMC10448789
|
biostudies-literature
Cite
Famotidine activates the vagus nerve inflammatory reflex to attenuate cytokine storm.
Not available
S-EPMC9016653
|
biostudies-literature
Cite
Famotidine activates the vagus nerve inflammatory reflex to attenuate cytokine storm.
Not available
S-EPMC9109205
|
biostudies-literature
Cite
COVID-19: Famotidine, Histamine, Mast Cells, and Mechanisms.
Not available
S-EPMC8021898
|
biostudies-literature
Cite
The association between famotidine and in-hospital mortality of patients with COVID-19.
Not available
S-EPMC8662098
|
biostudies-literature
Cite
COVID-19: Famotidine, Histamine, Mast Cells, and Mechanisms.
Not available
S-EPMC9793841
|
biostudies-literature
Cite
COVID-19: Famotidine, Histamine, Mast Cells, and Mechanisms.
Not available
S-EPMC7336703
|
biostudies-literature
Cite
Famotidine inhibits toll-like receptor 3-mediated inflammatory signaling in SARS-CoV-2 infection.
Not available
S-EPMC8241579
|
biostudies-literature
Cite
Previous
page
1 / 15
You're on page
1
page
2
page
3
page
4
page
5
page
...
page
15
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets
